Thus, in view of a potential novel pharmacological challenge, the aim of our study was to assess whether administration of a pharmacological HO-1 activation, when chances to save ischemic myocardium are greatly reduced or even nil, has any effect on MI outcome. Here, HMOX1 is linked to myocardial infarction.